Skip to main content
Access Bio, Inc. logo

Access Bio, Inc. — Investor Relations & Filings

Ticker · 950130 ISIN · KR8840090003 LEI · 335800Q5TV77F4L9Q648 KO Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2019-02-27 Proxy Solicitation & In…
Country IN India
Listing KO 950130

About Access Bio, Inc.

https://accessbio.net/

Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Access Bio. It outlines the date, location, and agenda items (financial statement approval, director appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2019-02-27 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a short regulatory filing (592 characters) submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains the scheduling conflict for the AGM and provides the date. Since it is a regulatory notification regarding meeting logistics rather than the AGM presentation materials themselves, and it is a short announcement, it falls under the general regulatory filing category.
2019-02-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document tracks changes in share ownership by major shareholders and their special related parties. It does not fit into the 'Annual Report' or 'Interim Report' categories, nor is it an announcement of a report (RPA). It is a specific regulatory disclosure regarding ownership thresholds and changes, which falls under the 'Major Shareholding Notification' category.
2018-12-28 Korean
기타경영사항(자율공시)(제17기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
AGM Information Classification · 1% confidence The document is a regulatory announcement regarding the setting of a record date for the 17th Annual General Meeting (AGM) to determine shareholder voting rights. It is a short, formal notice (under 5,000 characters) issued by the company to inform shareholders of administrative procedures related to an upcoming meeting. Since it does not contain the full proxy materials or the meeting results, but rather serves as a regulatory notice of a procedural milestone, it falls under the general regulatory filing category.
2018-12-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual arrangements (such as collateral agreements) of major shareholders. This falls under the category of Major Shareholding Notification (MRQ).
2018-11-28 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Access Bio, Inc. covering the period from January 1, 2018, to September 30, 2018. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.